{"id":21680,"date":"2023-08-23T23:05:41","date_gmt":"2023-08-23T17:35:41","guid":{"rendered":"https:\/\/digitalmarketingdeal.com\/blog\/?p=21680"},"modified":"2023-08-24T23:20:20","modified_gmt":"2023-08-24T17:50:20","slug":"biotech-companies-in-san-francisco","status":"publish","type":"post","link":"https:\/\/digitalmarketingdeal.com\/blog\/biotech-companies-in-san-francisco\/","title":{"rendered":"Biotech companies in San Francisco CA, United States List August 2023 Updated"},"content":{"rendered":"

1.TeselaGen Biotechnology Inc.<\/b><\/span><\/p>\n

Large companies that participate in the bio-economy are replacing traditional technologies with modern synthesis and machine learning driven techniques. This modern approach coupled with machine learning has opened the door for a radical transformation of biology and a rapid expansion of potential applications. This increased demand requires a secure, scalable, interoperable, protocol-driven platform that can span multiple users working on multiple projects across large, geographically distributed organizations. These new approaches are pushing companies to update their product development methods and IP strategies to maintain their lead and competitive advantage.\u00a0<\/span><\/p>\n

APPLICATIONS<\/span><\/p>\n

BIOPHARMACEUTICALS<\/span><\/p>\n

INDUSTRIAL BIOTECHNOLOGY<\/span><\/p>\n

AGRICULTURAL BIOTECHNOLOGY<\/span><\/p>\n

Contact no:+1 650-387-5932<\/span><\/p>\n

Address: 1501 Mariposa St #312, San Francisco, CA 94107, United States<\/span><\/p>\n

Website:https:\/\/teselagen.com\/<\/a><\/span><\/strong><\/p>\n

2.MBC BioLabs<\/span><\/strong><\/p>\n

By fundamentally changing the approach to life science research, we give entrepreneurs the playground to be creative. We lower the barriers to entry, minimize the start-up hurdles and provide a launchpad to take theories from hypothesis to data. Because we believe their success will not only change their business, it will impact the lives of many.<\/span><\/p>\n

In 2006, Doug Crawford repurposed a utility room at the Mission Bay campus of the University of California and the QB3 Garage was born. As the first technology incubator in the UC system, the Garage was met with skepticism. \u201cIt\u2019ll never work,\u201d their advisory board said. \u201cIt\u2019ll be an intensive care unit for sick companies.\u201d But of the first six startups, four raised Series A venture funding and a fifth was acquired for $25 million \u2013 and all within the first two years.<\/span><\/p>\n

As word spread, so did demand. Entrepreneurial scientists were drawn to the easy access of lab benches and equipment and the camaraderie of being around other entrepreneurs. Keeping that in mind, Doug jumped on the opportunity to lease and completely transform a warehouse in San Francisco in 2013. The result was MBC BioLabs, a full-service incubator offering laboratories, office space, meeting rooms, and an in-house staffed CRO facility with millions of dollars\u2019 worth of equipment. Within six months, it was at full occupancy.<\/span><\/p>\n

Now with over 50 resident companies, an extensive list of successful alumni companies, and a second location in San Carlos, MBC BioLabs is the premier biotech incubator in the Bay Area. And we\u2019re just getting started.<\/span><\/p>\n

Services<\/span><\/p>\n

Mentorship<\/span><\/p>\n

Lab Services<\/span><\/p>\n

Hot Bench Program<\/span><\/p>\n

Access to Capital<\/span><\/p>\n

Contact no:+1 415-347-8287<\/span><\/p>\n

Address: 953 Indiana St, San Francisco, CA 94107, United States<\/span><\/p>\n

Website:https:\/\/mbcbiolabs.com\/<\/a><\/span><\/strong><\/p>\n

3.FibroGen, Inc.<\/span><\/strong><\/p>\n

We work at the intersection of groundbreaking science and patient need. Our research and development teams seek to identify and develop innovative drugs with the greatest promise of becoming first-in-class medicines for the treatment of chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis, pancreatic cancer, Duchenne muscular dystrophy and COVID-19. Our product candidates leverage the body\u2019s natural pathways, providing us with the scientific insight to investigate their potential across multiple diseases.<\/span><\/p>\n

Roxadustat, our most advanced therapeutic, is an oral small molecule inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylase, the enzyme that regulates HIF activity. By transiently inhibiting the enzyme, roxadustat induces the body\u2019s natural coordinated process of producing red blood cells, increasing iron absorption, mobilization, and transport.<\/span><\/p>\n

Pipeline<\/span><\/p>\n

R&D Pipeline<\/span><\/p>\n

Roxadustat<\/span><\/p>\n

Pamrevlumab<\/span><\/p>\n

Contact no: +1 415-978-1200<\/span><\/p>\n

Address:409 Illinois St, San Francisco, CA 94158, United States<\/span><\/p>\n

Website:https:\/\/www.fibrogen.com\/<\/a><\/span><\/strong><\/p>\n

4.Mandalmed<\/b><\/span><\/p>\n

MandalMed is a privately-held company focused on modulation of glycobiology and innate immunity to develop treatments for organ fibrosis. The initial target is galectin-3, one of a family of carbohydrate binding proteins. The lead product is MM-003, a protein inhibitor of galectin-3, for prevention and reversal of fibrosis after myocardial infarction and in heart failure.\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><\/p>\n

Contact no: +1 415-495-5570<\/span><\/p>\n

Address:: 665 3rd St #250, San Francisco, CA 94107, United States<\/span><\/p>\n

Website:https:\/\/www.mandalmed.com\/<\/a><\/span><\/strong><\/p>\n

5.Nurix<\/b><\/span><\/p>\n

NURIX THERAPEUTICS IS COMMITTED TO BRINGING NOVEL, FIRST-IN-CLASS THERAPIES TO PATIENTS WHO DO NOT HAVE ADEQUATE TREATMENT OPTIONS. OUR SMALL MOLECULE DRUGS ARE DESIGNED TO MODULATE PROTEIN LEVELS IN CELLS AS A NEW TREATMENT APPROACH FOR A BROAD RANGE OF DISEASES.<\/span><\/p>\n

Nurix\u2019s therapies control E3 ubiquitin ligases, the key enzymes responsible for protein breakdown within the natural cellular process. With our unique DELigase platform, we can both increase and decrease protein levels, by either harnessing or inhibiting the activity of the appropriate E3 ligase, to treat many different diseases. Currently, we are focused on developing targeted therapies for cancer including novel, small molecule immuno-oncology agents.<\/span><\/p>\n

Nurix was founded by a team of internationally renowned scientific experts in the E3 ubiquitin ligase regulation and structure field. Since incorporation, the company has built a seasoned team of leaders with wide-ranging backgrounds in small molecule drug development. Nurix is funded by leading life sciences investors and corporate partners and is headquartered in San Francisco, California.<\/span><\/p>\n

Services<\/b><\/span><\/p>\n

E3 LIGASE PLATFORMS<\/span><\/p>\n

PIPELINE\u00a0<\/span><\/p>\n

STRATEGIC PARTNERSHIPS<\/span><\/p>\n

Contact no:+1 415-660-5320<\/span><\/p>\n

Address:<\/b> 1700 Owens St #290, San Francisco, CA 94158, United States<\/span><\/span><\/p>\n

Website:<\/b>https:\/\/www.nurixtx.com\/<\/strong><\/a><\/span><\/p>\n

6.IndieBio<\/b><\/span><\/p>\n

Each team receives $250,000 in seed funding, lab and co-working space, dedicated mentorship, and becomes part of a huge network of IndieBio alumni, investors, biotech entrepreneurs, investors, press, corporate partners, and more.<\/span><\/p>\n

For each IndieBio program, early-stage biology companies move to downtown San Francisco or New York City to take part in an intense 4-month program unlike anything they\u2019ve ever experienced in their PhD\u2019s and Post-doctoral training. Founders engage with customers and partners, pitch to investors, and turn science into a real product people pay for. Both locations run 2 programs with 15 companies each year.<\/span><\/p>\n

Address<\/b>: 479 Jessie St, San Francisco, CA 94103, United States<\/span><\/span><\/p>\n

Website:<\/b>https:\/\/indiebio.co\/<\/strong><\/a><\/span><\/p>\n

7.Prosetta Biosciences, Inc.<\/b><\/span><\/p>\n

The fundamental tenet of molecular biology is that information coded in the genetic material (DNA) is ultimately converted into proteins. Proteins come in many classes: there are structural proteins such as collagen that hold the body together, signaling proteins such as insulin that make storage and use of energy possible, and defensive proteins such as antibodies that protect the body from infection. Another extremely important class of proteins are the enzymes. Enzymes are proteins which speed up chemical reactions, a process termed catalysis. Without enzymes, life would not be possible. Each enzyme is fairly specific for a particular chemical reaction, but chemical reactions don\u2019t occur in isolation from one another. Rather, they are organized into pathways. These are sets of chemical reactions, catalyzed by enzymes, that bring about features essential for life, such as breaking food down into components to generate chemical energy, repairing and building the components of cells and tissues of the body, and so forth.<\/span><\/p>\n

Programs<\/b><\/span><\/p>\n

ALS Program<\/span><\/p>\n

Pan Respiratory Antiviral Program<\/span><\/p>\n

Oncology Program<\/span><\/p>\n

Parkinson’s Program<\/span><\/p>\n

HIV Program<\/span><\/p>\n

Rabies Program<\/span><\/p>\n

Exploratory Applications<\/span><\/p>\n

Contact no: <\/b>+1 415-346-8866<\/span><\/span><\/p>\n

Address: <\/b>670 5th St, San Francisco, CA 94107, United States<\/span><\/span><\/p>\n

Website<\/b>:https:\/\/prosetta.com\/<\/strong><\/a><\/span><\/span><\/p>\n

8.VIR Biotechnology<\/b><\/span><\/p>\n

We are a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Infectious diseases are one of the leading causes of death worldwide and the cause of hundreds of billions of dollars of economic burden each year. We believe that now is the time to apply the recent and remarkable advances in immunology to combat infectious diseases. Our approach begins with identifying the limitations of the immune system in combating a particular pathogen, the vulnerabilities of that pathogen and the reasons why previous approaches have failed. We then bring to bear powerful technologies that we believe, individually or in combination, will lead to effective therapies.<\/span><\/p>\n

Science<\/span><\/p>\n

Platforms<\/span><\/p>\n

Literature Archive<\/span><\/p>\n

Contact no:<\/b> +1 415-906-4324<\/span><\/span><\/p>\n

Address: <\/b>499 Illinois St, San Francisco, CA 94158, United States<\/span><\/span><\/p>\n

Website:<\/b>https:\/\/www.vir.bio\/<\/strong><\/a><\/span><\/p>\n

9.Audentes Therapeutics<\/b><\/span><\/p>\n

Our investigational therapies target rare diseases through three modalities: gene replacement, exon skipping gene therapy and vectorized RNA knockdown. We are leveraging Astellas\u2019 global resources, industry leadership in immune biology, and deep scientific expertise to expand our reach and develop valuable new genetic medicines for patients around the world.<\/span><\/p>\n

InnovativeTherapies<\/span><\/p>\n

X-Linked Myotubular Myopathy<\/span><\/p>\n

Pompe Disease<\/span><\/p>\n

Duchenne Muscular Dystrophy<\/span><\/p>\n

Myotonic Dystrophy Type 1<\/span><\/p>\n

Expanded Access Policy<\/span><\/p>\n

Contact no:<\/b>+1 415-818-1001<\/span><\/span><\/p>\n

Address:<\/b> 600 California St #17, San Francisco, CA 94108, United States<\/span><\/span><\/p>\n

Website:<\/b>https:\/\/www.audentestx.com\/<\/strong><\/a><\/span><\/p>\n

10.Lentigen Corporation<\/b><\/span><\/p>\n

Biomark Capital provides venture funding and assistance to early, mid, and late-stage life science companies. We target companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health that will change the face of healthcare innovation in the future. We share the drive and vision of our portfolio companies to collaborate with them in accelerating growth and building successful business ventures.<\/span><\/p>\n

Biomark Capital is a venture capital and private equity firm comprised of experienced professionals with over 50 years of combined investment experience generating superior returns.<\/span><\/p>\n

A confluence of events is changing healthcare globally and worldwide healthcare spending continues to grow at a rapid pace. Biomark Capital believes now is a compelling time to invest in game changing technologies that can broaden the foundation of healthcare practice, change the face of patient care, improve quality of life, and generate superior returns for our investors.<\/span><\/p>\n

Impact global healthcare by investing our capital and expertise on the most promising and best-in-class life science companies. Biomark Capital\u2019s primary investment focus is in North America, along with a specific focus in Russia, Taiwan, India, and China. Our initial investments typically range from $5-$10 million dollars with key investment criteria including:<\/span><\/p>\n

\u30fb \u00a0 \u00a0 \u00a0 Highly Disruptive Innovation<\/span><\/p>\n

\u30fb \u00a0 \u00a0 \u00a0 Large Clinical Unmet Medical Need<\/span><\/p>\n

\u30fb \u00a0 \u00a0 \u00a0 Freedom-to-Operate \/ LargeBarriers to Entry<\/span><\/p>\n

\u30fb \u00a0 \u00a0 \u00a0 Established Proof-of-Concept<\/span><\/p>\n

\u30fb \u00a0 \u00a0 \u00a0 Strong Management Team<\/span><\/p>\n

Contact no:<\/b> +1 415-249-0845<\/span><\/span><\/p>\n

Address<\/b>: 450 Sansome St #1005, San Francisco, CA 94111, United States<\/span><\/span><\/p>\n

Website<\/b>:http:\/\/www.biomarkcapital.com\/<\/strong><\/a><\/span><\/span><\/p>\n

FAQs: Biotech companies in San Francisco<\/strong><\/span><\/h2>\n

1. What are some renowned biotech companies in San Francisco?<\/strong> Discover the most prominent biotech companies driving innovation in San Francisco, contributing to groundbreaking advancements in the field.<\/span><\/p>\n

2. How is San Francisco’s biotech industry contributing to healthcare?<\/strong> Learn about the impactful contributions of San Francisco’s biotech sector to healthcare, including pharmaceuticals, medical devices, and therapies.<\/span><\/p>\n

3. What makes San Francisco a hub for biotech innovation?<\/strong> Explore the factors that have made San Francisco a hotbed for biotech innovation, from research institutions to investment opportunities.<\/span><\/p>\n

4. Are there networking opportunities in San Francisco’s biotech sector?<\/strong> Find out about networking events, conferences, and meetups where professionals in the biotech industry gather to exchange ideas and foster collaborations.<\/span><\/p>\n

5. What recent advancements have emerged from San Francisco’s biotech scene?<\/strong> Stay updated on the latest breakthroughs in biotechnology that have originated from San Francisco, shaping the future of medicine and science.<\/span><\/p>\n

6. How does the collaboration between biotech and technology happen in San Francisco?<\/strong> Learn how the synergy between biotech and technology sectors in San Francisco is driving advancements in areas like bioinformatics and digital health.<\/span><\/p>\n

7. What career prospects are available in San Francisco’s biotech field?<\/strong> Explore the diverse career opportunities in the biotech industry in San Francisco, from research and development to business and management roles.<\/span><\/p>\n

8. How does San Francisco support startups in the biotech sector?<\/strong> Discover the resources, incubators, and funding options available to biotech startups in San Francisco, fostering entrepreneurial growth.<\/span><\/p>\n

9. Are there educational programs focused on biotech in San Francisco?<\/strong> Find information about educational institutions and programs in San Francisco that offer training and degrees in biotechnology-related disciplines.<\/span><\/p>\n

10. What role does government policy play in San Francisco’s biotech growth?<\/strong> Understand the influence of government policies and regulations on the growth and sustainability of the biotech industry in San Francisco.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

1.TeselaGen Biotechnology Inc. Large companies that participate in the bio-economy are replacing traditional technologies with<\/p>\n","protected":false},"author":23,"featured_media":21697,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6865],"tags":[],"class_list":["post-21680","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-san-francisco"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/digitalmarketingdeal.com\/blog\/wp-json\/wp\/v2\/posts\/21680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/digitalmarketingdeal.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/digitalmarketingdeal.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/digitalmarketingdeal.com\/blog\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/digitalmarketingdeal.com\/blog\/wp-json\/wp\/v2\/comments?post=21680"}],"version-history":[{"count":2,"href":"https:\/\/digitalmarketingdeal.com\/blog\/wp-json\/wp\/v2\/posts\/21680\/revisions"}],"predecessor-version":[{"id":144323,"href":"https:\/\/digitalmarketingdeal.com\/blog\/wp-json\/wp\/v2\/posts\/21680\/revisions\/144323"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/digitalmarketingdeal.com\/blog\/wp-json\/wp\/v2\/media\/21697"}],"wp:attachment":[{"href":"https:\/\/digitalmarketingdeal.com\/blog\/wp-json\/wp\/v2\/media?parent=21680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/digitalmarketingdeal.com\/blog\/wp-json\/wp\/v2\/categories?post=21680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/digitalmarketingdeal.com\/blog\/wp-json\/wp\/v2\/tags?post=21680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}